Chronic kidney disease trials in Romania

In Romania 14 Also abroad 798

14 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Where
Bucharest, Cluj-Napoca, Craiova, Oradea, Suceava, Timisoara
Age
18 years and over
People
5,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00
Phase 3Taking people
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Where
Baia Mare, Baloteşti, Brasov, Bucharest, Iași, Maramureș, Oradea, Ploiesti, Satu Mare, Sibiu, Targu Mures, Târgu Mureş, Timisoara
Age
50 years and over
People
7,140 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00
Phase 4Taking people
Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus
Where
Bucharest
Age
18 years and over
People
200
Run by
Anemia Working Group Romania
See details and how to joinNCT06281899
Phase 3Taking people
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Where
Brasov, Bucharest, Craiova, Galati, Oradea, Timișoara
Age
18 years to 99 years
People
2,800 worldwide
Run by
AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00
Phase 2/3Taking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Brasov, Bucharest, Cluj-Napoca, Constanța, Craiova, Deva, Iași, Oradea, Ploieşti, Satu Mare, Târgu Mureş
Age
18 years and over
People
3,110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
Phase 3Taking people
Efepoetin alfa for treatment of anemia in chronic kidney disease on dialysis
Where
Bucharest, Craiova
Age
18 years and over
People
337 worldwide
Run by
Genexine Inc.
See details and how to join2023-503634-50-01 · EU 2023-503634-50-01
Phase 3Taking people
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Where
Brasov, Bucharest, Cluj-Napoca, Iasi, Oradea, Ploieşti, Timisoara
Age
18 years and over
People
7,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00
Phase 1Not yet taking people in Romania
A Participant- and Investigator--Blinded, Placebo-Controlled, Randomized, Multipart, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants with Chronic Kidney Disease
Where
Bucharest, Cluj-Napoca
Age
18 years and over
People
44 worldwide
Run by
Novartis Pharma AG
See details and how to join2025-520978-18-00 · EU 2025-520978-18-00
No phaseNot yet taking people in Romania
Atrial Cardiomyopathy in Patients With Cardiovascular-Kidney-Metabolic Syndrome: Non-invasive Characterization
Where
Iași
Age
18 years and over
People
200
Run by
Grigore T. Popa University of Medicine and Pharmacy
See details and how to joinNCT07697469
No phaseNot yet taking people in Romania
Euvolemia-Based Assessment of Pulmonary Hypertension in Stable Hemodialysis Patients
Where
Bucharest
Age
18 years and over
People
30
Run by
Stefan Lujinschi
See details and how to joinNCT07676786
No phaseTaking people
Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)
Where
Bucharest
Age
18 years and over
People
100
Run by
Stefan Lujinschi
See details and how to joinNCT07575347
Phase 2Taking people
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
Where
Oradea
People
28 worldwide
Run by
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
See details and how to joinNCT04580420
No phaseTaking people
Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients
Where
Iași
Age
18 years and over
People
200
Run by
Grigore T. Popa University of Medicine and Pharmacy
See details and how to joinNCT07237451
No phaseTaking people
Assessment of Mineral and Bone Disorders in Kidney Transplant Recipients
Where
Iași
Age
20 years to 70 years
People
180
Run by
Grigore T. Popa University of Medicine and Pharmacy
See details and how to joinNCT07141043